REM sleep deprivation before extinction or reinstatement alters methamphetamine reward memory via D1-like dopamine receptors.


Journal

Pharmacology, biochemistry, and behavior
ISSN: 1873-5177
Titre abrégé: Pharmacol Biochem Behav
Pays: United States
ID NLM: 0367050

Informations de publication

Date de publication:
02 2022
Historique:
received: 03 05 2021
revised: 26 11 2021
accepted: 25 12 2021
pubmed: 7 1 2022
medline: 9 3 2022
entrez: 6 1 2022
Statut: ppublish

Résumé

We aimed to determine whether REM sleep deprivation (RSD) affects extinction and reinstatement of methamphetamine (METH) reward memory in male rats and also to evaluate the possible role of dopamine D1-like and D2-like dopamine (DA) receptors in these processes. Male rats were trained to acquire METH-induced place preference (2 mg/kg, i.p.). METH reward memory was then reinstated following a 10-day extinction period. The animals underwent a 72-hour sleep deprivation episode by multiple platforms method (in separate groups), either before the extraction or before the reinstatement of METH reward memory. The animals received SCH 23390 (0.01 or 0.05 mg/kg, i.p.) or sulpiride (20 or 60 mg/kg, i.p.) as antagonists of D1-like and D2-like DA receptors, respectively, either immediately following each daily extinction session or before the reinstatement of METH-seeking behavior. The RSD episode postponed extinction and facilitated reinstatement of METH reward memory. Administration of SCH 23390, but not sulpiride, facilitated METH extinction and decreased reinstatement of the extinguished METH-seeking behavior. Moreover, locomotor activity was not affected by METH and/or the RSD paradigm. The results would seem to suggest that the D1-like, but not the D2-like, DA receptors may be involved in the extinction and reinstatement of the extinguished METH reward memory in RSD animals. Nonetheless, more investigations are needed to elucidate the exact mechanisms involved.

Identifiants

pubmed: 34990706
pii: S0091-3057(21)00218-5
doi: 10.1016/j.pbb.2021.173319
pii:
doi:

Substances chimiques

Benzazepines 0
Dopamine Agents 0
Receptors, Dopamine D1 0
Receptors, Dopamine D2 0
SCH 23390 0
Methamphetamine 44RAL3456C
Sulpiride 7MNE9M8287

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

173319

Informations de copyright

Copyright © 2021. Published by Elsevier Inc.

Auteurs

Kaveh Shahveisi (K)

Sleep Disorders Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran.

Nasrin Abdoli (N)

Substance Abuse Prevention Research Center, Health Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran.

Vahid Farnia (V)

Substance Abuse Prevention Research Center, Health Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran.

Habibolah Khazaie (H)

Sleep Disorders Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran.

Mahmoud Hosseini (M)

Division of Neurocognitive Sciences, Psychiatry and Behavioral Sciences Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.

Hamed Ghazvini (H)

Department of Neuroscience, School of Advanced Technologies in Medicine, Mazandaran University of Medical Sciences, Sari, Iran.

Mehdi Khodamoradi (M)

Substance Abuse Prevention Research Center, Health Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran. Electronic address: mehdi.khodamoradi@kums.ac.ir.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH